Neurological complications of acute and persistent Epstein-Barr virus infection in paediatric patients
✍ Scribed by Martin Häusler; Vincent Thomas Ramaekers; Martin Doenges; Klaus Schweizer; Klaus Ritter; Lars Schaade
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 373 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Neurological complications of Epstein-Barr virus (EBV) have been reported almost exclusively in the course of acute primary infections. The role of EBV in paediatric neurological disease was investigated prospectively over a 2-year period, searching for acute primary, chronic, and reactivated EBV infections. Active EBV infections were diagnosed in 10/48 patients, including two with acute primary EBV infections (cranial neuritis and cerebellitis), one with chronic active infection (T/NK cell lymphoma with cranial neuritis), and seven with reactivated infections. Among these seven patients, three showed "Alice in Wonderland" syndrome, one facial nerve palsy, one progressive macrocephaly, and two prolonged encephalitic illness. The prognosis was good except for the patient with lethal T/NK cell lymphoma and the two girls with encephalitic illness. Despite steroid treatment, these girls suffered prolonged cognitive impairment and epileptic seizures. Both developed left-sided hippocampal atrophy, and one of them hippocampal sclerosis. Like primary infections, reactivated EBV infections cause neurological complications in a considerable number of paediatric patients, lead to serious long-term complications, and may contribute to the pathogenesis of hippocampal lesions.
📜 SIMILAR VOLUMES
## Abstract Two Epstein Barr virus (EBV) genotypes: EBV‐1 and EBV‐2 have been described. A 30‐bp deletion in latent membrane protein‐1 gene (del‐LMP‐1) has been identified in various pathologies. The aim of this study was to determine EBV genotypes and 30‐bp deletion frequency in HIV‐infected patie
A seroepidemiological study was carried out on 502 sera to determine the prevalence of EBV infection in a group of Bangladeshi people (age range: 15 days-90 years). All sera were tested for IgG antibody to the EBV viral capsid antigen (VCA) by a commercially available enzyme linked immunosorbent ass
## Abstract The influence of an acute Epstein‐Barr virus (EBV) infection on the serological parameters of persistent varicella‐zoster virus (VZV) and herpes simplex virus (HSV) was studied. Sera from 161 patients with infectious mononucleosis caused by EBV and 178 age‐matched controls were tested f
## Abstract The presence of Epstein‐Barr virus (EBV) in the blood and urine of 20 patients with infectious mononucleosis (IM) was investigated together with the clinical course of the disease, and in 9 patients up to 2–7 months after recovery. EBV DNA, analyzed by the polymerase chain reaction (PCR